⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8991581 | 1.00 | — | — | |
| SCHEMBL8146654 | 1.00 | — | — | |
| SCHEMBL28636621 | 0.98 | — | — | |
| SCHEMBL12962139 | 0.86 | — | — | |
| SCHEMBL11999135 | 0.84 | — | — | |
| SCHEMBL29183013 | 0.81 | — | — | |
| SCHEMBL24575777 | 0.76 | — | — | |
| SCHEMBL21896082 | 0.76 | — | — | |
| SCHEMBL41166 | 0.76 | — | — | |
| SCHEMBL11287329 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1267 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125722-A1 | METHOD FOR PRODUCING METHYL COMPOUND | MITSUBISHI CHEMICAL CORPORATION (JP) | 2026-05-07 | — | — | US | claimed |
| EP-4692361-A1 | METHOD FOR PRODUCING METHYL COMPOUND | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| EP-4692363-A1 | METHOD FOR PRODUCING METHYL COMPOUND | Mitsubishi Chemical Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| US-20250352625-A1 | METHODS AND COMPOSITIONS FOR METHIONINE RESTRICTION | PETRI BIO, INC. (US) | 2025-11-20 | — | — | US | claimed |
| EP-4531881-A2 | METHODS AND COMPOSITIONS FOR METHIONINE RESTRICTION | Petri Bio, Inc. (US) | 2025-04-09 | — | — | EP | claimed |
| WO-2024204792-A1 | METHOD FOR PRODUCING METHYL COMPOUND | 三菱ケミカル株式会社 | 2024-10-03 | — | — | WO | claimed |
| WO-2024204791-A1 | METHOD FOR PRODUCING METHYL COMPOUND | 三菱ケミカル株式会社 | 2024-10-03 | — | — | WO | claimed |
| CN-117660283-A | Recombinant genetically engineered bacterium for increasing intracellular NADPH level and application thereof in L-methionine production | 浙江工业大学 | 2024-03-08 | — | — | CN | claimed |
| WO-2023235846-A2 | METHODS AND COMPOSITIONS FOR METHIONINE RESTRICTION | PETRI BIO, INC. (US) | 2023-12-07 | — | — | WO | claimed |
| EP-3180390-B1 | POLYMER FOR TISSUE ENGINEERING | UNIV LINZ (AT) | 2020-11-25 | — | — | EP | claimed |
| EP-0751779-A4 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORP (US) | 1998-12-09 | — | — | EP | claimed |
| EP-0751779-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1997-01-08 | — | — | EP | claimed |
| WO-1995034303-A1 | METHOD FOR THE TREATMENT, PREVENTION OR MINIMIZATION OF HAIR LOSS | ARCTURUS PHARMACEUTICAL CORPORATION (US) | 1995-12-21 | — | — | WO | claimed |
| WO-1995000165-A1 | SELECTIVELY CLEAVABLE LINKERS BASED ON IMINODIACETIC ACID ESTER BONDS | SELECTIDE CORPORATION (US) | 1995-01-05 | — | — | WO | claimed |
| EP-0575482-A1 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1993-12-29 | — | — | EP | claimed |
| WO-1992014743-A2 | ANTIVIRAL ACTIVITY AND RESOLUTION OF 2-HYDROXYMETHYL-5-(5-FLUOROCYTOSIN-1-YL)-1,3-OXATHIOLANE | EMORY UNIVERSITY (US) | 1992-09-03 | — | — | WO | claimed |
| EP-0237082-B1 | 3,5-DISUBSTITUTED 4,5-DIHYDROISOXAZOLES AS TRANSGLUTAMINASE INHIBITORS | SYNTEX (U.S.A.) INC. (US) | 1991-05-29 | — | — | EP | claimed |
| EP-0376012-A2 | Renin inhibitors | AMERICAN CYANAMID COMPANY (US) | 1990-07-04 | — | — | EP | claimed |
| EP-0237082-A2 | 3,5-disubstituted 4,5-dihydroisoxazoles as transglutaminase inhibitors | SYNTEX (U.S.A.) INC. (US) | 1987-09-16 | — | — | EP | claimed |
| US-4661443-A | FORMATION OF INITIAL NH2-TERMINAL DIPEPTIDES AND TRIPEPTIDES | HOFFMANN-LA ROCHE INC. (US) | 1987-04-28 | — | — | US | claimed |